News
October 9, 2007 – Medtronic Inc. today announced that it has begun enrolling in the PRECEDE-HF clinical trial that will evaluate Medtronic’s proprietary Cardiac Compass and OptiVol Fluid Status Monitoring features to determine whether cardiac trend data may help physicians prevent heart failure hospitalizations or deaths compared to standard clinical assessment alone.
October 08, 2007
News
October 9, 2007 - Physio-Control Inc., a wholly owned subsidiary of Medtronic, Inc., today announced that the LUCAS Chest Compression System is available in the U.S. through an exclusive distribution partnership with JOLIFE AB, expanding its reach of its emergency medicine device portfolio.
October 08, 2007News
October 9, 2007 - Biophan Technologies Inc., a developer of biomedical technology, announced it has closed the $11 ...
October 08, 2007Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024Technology
October 8, 2007 - Cincinnati Sub-Zero (CSZ) Products Inc. released its Kool Kit noninvasive, integrated, whole-body hypothermia system in September.
October 07, 2007News
October 8, 2007 - Enova Medical Technologies said today it developed new LED technology for cordless surgical headlights ...
October 07, 2007News
October 8, 2007 - Drug-eluting stents were found to be most effective in reducing the need for repeat angioplasty ...
October 07, 2007Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
October 5, 2007 - InSite One Inc. recently announced the signing of a co-marketing agreement with Technology Imaging ...
October 04, 2007News
October 5, 2007 – Royal Philips Electronics announced it will acquire U.S.-based Raytel Cardiac Services, a division of ...
October 04, 2007News
October 4, 2007 – The Cleveland Clinic announced Oct. 3 its Top 10 Medical Innovations list, highlighting technologies ...
October 03, 2007Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023News
October 4, 2007 – The acute success rate in patients treated for atrial fibrillation with the Niobe magnetic navigation ...
October 03, 2007News
October 4, 2007 – Aloka recently announced that the company will unveil three new models of its ProSound Systems, the ...
October 03, 2007News
October 3, 2007 - Researchers at Cedars-Sinai Medical Center’s S. Mark Taper Foundation Imaging Center announced that ...
October 02, 2007Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
October 3, 2007 - Crux Biomedical Inc., a medical device firm, announced it recently completed the first implant in the ...
October 02, 2007News
October 3, 2007 - The American Society of PeriAnesthesia Nurses (ASPAN) today issued a 10-step action plan to address ...
October 02, 2007News
October 1, 2007 – GE Global Research, the General Electric Company’s centralized research and development organization, and GE Healthcare today announced a three-year collaborative research agreement with Eli Lilly and Company to discover and develop advanced in vitro diagnostic assays that may predict cancer treatment response to targeted therapies.
October 01, 2007© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now